Fertility Centers Of Illinois Seeks In Vitro Fertilization Patients For Clinical Trial Of Investigational Drug That Promotes Pregnancy

Main Category: Fertility
Also Included In: Pregnancy / Obstetrics
Article Date: 10 Mar 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

4.8 (5 votes)

Healthcare Prof:not yet rated


Fertility Centers of Illinois S.C., (FCI) along with several other large infertility practices nationwide, have been selected to participate in a Phase III Clinical Trial for an investigational drug that supports pregnancy and is used with In Vitro Fertilization (IVF). FCI seeks up to 200 patients to take part in the study and is offering one cycle of In Vitro Fertilization (IVF) at no cost to all that meet the study criteria.

All patients taking part in the study will be required to take daily injections of gonadotropins to prepare the eggs, similar to a typical IVF cycle. Half of patients will be randomized into a group taking the FDA approved drug and the other half will take the investigational drug. Randomization to the progesterone treatment group will occur after a patient has reached egg retrieval.

Initially, participants of the study must be seen at the FCI River North office; however subsequent monitoring can be performed at either of the In Vitro Fertilization Centers at Highland Park or River North. Oocyte retrieval and embryo transfer will be performed at the designated IVF facility. Following embryo transfer, additional embryos can be frozen, but at the cost to the patient. As with all drug studies, strict criteria for participation apply. Please visit http://www.fcionline.com for further information about the application process and criteria for inclusion and exclusion from the program.

About Fertility Centers Of Illinois

Fertility Centers of Illinois, S.C., is one of the nation's leading infertility treatment practices, providing advanced reproductive endocrinology services in the Chicago area for over 25 years. FCI has more babies born than the next ten centers combined with high success rates that are recognized throughout the nation. In addition to a team of nationally recognized reproductive physicians who stay current on the latest technology and procedures, FCI patients have access to many other unique support services, such as professional counseling from a licensed, Ph.D. clinical psychologist, patient advocates and innovative financial options. FCI is part of IntegraMed, the nation's largest and most reputable network of fertility centers and has multiple offices conveniently located throughout the Chicago area.

Fertility Centers Of Illinois

Article adapted by Medical News Today from original press release.
Visit our fertility section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Fertility Centers Of Illinois. "Fertility Centers Of Illinois Seeks In Vitro Fertilization Patients For Clinical Trial Of Investigational Drug That Promotes Pregnancy." Medical News Today. MediLexicon, Intl., 10 Mar. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/99906.php>

APA
Fertility Centers Of Illinois. (2008, March 10). "Fertility Centers Of Illinois Seeks In Vitro Fertilization Patients For Clinical Trial Of Investigational Drug That Promotes Pregnancy." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/99906.php.

Please note: If no author information is provided, the source is cited instead.


Fertility

Most Popular Articles



Follow Our Fertility News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Fertility Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »